当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 现金流量表

瑞康医药

(002589)

  

流通市值:45.34亿  总市值:49.96亿
流通股本:13.66亿   总股本:15.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,706,109,894.431,882,424,602.097,891,061,764.256,050,813,443.42
  客户存款和同业存放款项净增加额--0-
  向中央银行借款净增加额--0-
  向其他金融机构拆入资金净增加额--0-
  收到原保险合同保费取得的现金--0-
  收到再保险业务现金净额--0-
  保户储金及投资款净增加额--0-
  收取利息、手续费及佣金的现金--0-
  拆入资金净增加额--0-
  回购业务资金净增加额--0-
  收到的税费返还-07,099,709.6818,391.22
  收到其他与经营活动有关的现金193,922,105.3787,892,457.47307,955,980.87141,197,297.15
  经营活动现金流入的其他项目--0-
  经营活动现金流入小计3,900,031,999.81,970,317,059.568,206,117,454.86,192,029,131.79
  购买商品、接受劳务支付的现金3,245,775,074.71,762,239,1986,803,688,542.715,531,372,827.89
  客户贷款及垫款净增加额--0-
  存放中央银行和同业款项净增加额--0-
  支付原保险合同赔付款项的现金--0-
  支付利息、手续费及佣金的现金--0-
  支付保单红利的现金--0-
  支付给职工以及为职工支付的现金132,147,310.0271,456,107.29294,047,562.04212,858,232.01
  支付的各项税费69,863,477.139,415,965.57142,563,410.5996,633,053.02
  支付其他与经营活动有关的现金403,528,224.6694,988,863.72952,058,412.38310,588,836.18
  经营活动现金流出的其他项目--0-
  经营活动现金流出小计3,851,314,086.481,968,100,134.588,192,357,927.726,151,452,949.1
  经营活动产生的现金流量净额48,717,913.322,216,924.9813,759,527.0840,576,182.69
二、投资活动产生的现金流量:
  收回投资收到的现金--00
  取得投资收益收到的现金840,838.141,572,693.15597,850.320,513,453.57
  处置固定资产、无形资产和其他长期资产收回的现金净额1,279,718.47685,769.75532,730.1417,109,490.46
  处置子公司及其他营业单位收到的现金净额51,974,218.7815,022,608.4781,840,460.1454,751,353.35
  收到的其他与投资活动有关的现金850,000,000350,000,0001,615,420,000280,000,000
  投资活动现金流入小计904,094,775.39367,281,071.371,698,391,040.58372,374,297.38
  购建固定资产、无形资产和其他长期资产支付的现金18,073,243.4911,145,29426,820,905.2499,479,265.73
  投资支付的现金100,000,000100,000,000120,000,000-
  质押贷款净增加额--0-
  取得子公司及其他营业单位支付的现金-00-
  支付其他与投资活动有关的现金855,000,000350,000,0001,603,371,902.07400,000,000
  投资活动现金流出小计973,073,243.49461,145,2941,750,192,807.31499,479,265.73
  投资活动产生的现金流量净额-68,978,468.1-93,864,222.63-51,801,766.73-127,104,968.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金-020,000,00020,000,000
  其中:子公司吸收少数股东投资收到的现金-020,000,00020,000,000
  取得借款收到的现金2,537,575,720.531,306,688,4003,361,178,255.692,185,382,046.77
  收到其他与筹资活动有关的现金7,732,256,916.553,016,499,781.5217,466,819,244.0311,131,983,290.37
  筹资活动现金流入小计10,269,832,637.084,323,188,181.5220,847,997,499.7213,337,365,337.14
  偿还债务支付的现金1,959,931,778.84964,441,191.73,679,002,430.673,250,924,326.48
  分配股利、利润或偿付利息支付的现金118,691,573.677,831,827.04245,569,898.23181,126,511.31
  其中:子公司支付给少数股东的股利、利润68,144,384.3071,070,616.2821,000,000
  支付其他与筹资活动有关的现金7,984,239,617.892,988,136,649.3316,857,466,870.2710,018,814,417.63
  筹资活动现金流出小计10,062,862,970.334,030,409,668.0720,782,039,199.1713,450,865,255.42
  筹资活动产生的现金流量净额206,969,666.75292,778,513.4565,958,300.55-113,499,918.28
四、汇率变动对现金及现金等价物的影响--0-
五、现金及现金等价物净增加额186,709,111.97201,131,215.827,916,060.9-200,028,703.94
  加:期初现金及现金等价物余额718,238,986.97718,238,986.97690,322,926.07690,322,926.07
  期末现金及现金等价物余额904,948,098.94919,370,202.77718,238,986.97490,294,222.13
补充资料:
  净利润30,336,863.47-43,902,130.25-
  资产减值准备-35,843,573.03-26,501,315.05-
  固定资产和投资性房地产折旧52,298,287.8-111,981,410.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,298,287.8-111,981,410.17-
  无形资产摊销22,600,509.71-64,798,703.77-
  长期待摊费用摊销5,945,471.1-16,704,632.15-
  处置固定资产、无形资产和其他长期资产的损失-188,559.16--1,817,272.56-
  固定资产报废损失8,520.18-707,229.23-
  公允价值变动损失---4,902,905.63-
  财务费用94,896,124.55-186,867,399.22-
  投资损失-6,013,442.28--84,806,805.99-
  递延所得税7,364,759.13--40,373,226.76-
  其中:递延所得税资产减少9,565,465.36--36,834,552.13-
    递延所得税负债增加-2,200,706.23--3,538,674.63-
  存货的减少83,871,359.26-15,804,643-
  经营性应收项目的减少83,739,172.27-439,059,669.3-
  经营性应付项目的增加-290,819,304.67--763,019,695.96-
  现金的期末余额904,948,098.94-718,238,986.97-
  减:现金的期初余额718,238,986.97-690,322,926.07-
  现金及现金等价物的净增加额186,709,111.97-27,916,060.9-
公告日期2026-08-212026-04-252026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑